"cancer" News Stories

Biodesix Secures Medicare Coverage for VeriStrat® Test

Coverage of Predictive Biomarker Test Enables Lung Cancer Patients to Benefit From More-Informed Treatment Decisions Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that Novitas Solutions, the Medicare Administrative Contractor for the region that includes Colorado, h...

AIMM Therapeutics Significantly Strengthens Scientific Advisory Board with High Profile Appointments

Bob Löwenberg (Erasmus MC), John Mendelsohn (MD Anderson), and Hidde Ploegh (Whitehead Institute) to join AIMM SAB AIMM Therapeutics, a therapeutic antibody company, today announced the appointments of Bob Löwenberg, MD, PhD, John Mendelsohn, MD, and Hidde Ploegh, Ph.D. to the company’s Scientific Advisory Board (SAB). AIMM’s SAB oversee...

San Diego Life Sciences Roundup: Aragon, Santarus, Tocagen, and More

The $1 billion buyout of San Diego’s Aragon Pharmaceuticals is expected to greatly expand Johnson & Johnson’s drug pipeline for treating prostate cancer. We have that at the top of San Diego’s life sciences news, along with other developmen...

Charity warns of 'quite epidemic' of oesophageal cancer

Charity warns of 'quite epidemic' of oesophageal cancer

BerGenBio AS Announces Initiation of Phase I Clinical Trial for First-in-Class AXL Receptor Tyrosine Kinase Inhibitor BGB324 to Treat Aggressive and Metastatic Cancers

BerGenBio AS today announced the start of a Phase 1 Clinical Trial for BGB324, a first-in-class small molecule inhibitor of AXL tyrosine kinase. BGB324 is a highly selective, oral AXL inhibitor that blocks the epithelial-mesenchymal transition (EMT), which is a key driver of metastasis (cancer spread) and drug-resistance. The Phase 1 clinical trial of BGB3...

New PCC Issue Brief Indicates Health Care Reform Can Boost Colorectal Cancer Screening Rates, Reduce Mortality Among Americans

Preventing Colorectal Cancer's Issue Brief #5, The Impact of Health Insurance Reform on Colorectal Cancer, examines how the Patient Protection and Affordable Care Act (PPACA) expands Americans’ access to health care procedures such as colorectal cancer screening, which will lead to more people undergoing routine screening for colorectal cancer. Annapolis, MD (PRWEB) June 20, 2013 Preventing...

Lung Cancer Asbestos Victims Center Urges Victims Of Mesothelioma Or Lung Cancer To Call Them About Financial Compensation If They Were exposed To Asbestos At Work

The Lung Cancer Asbestos Victims Center is now urging any diagnosed victim of mesothelioma, or lung cancer victim to call them if they were exposed to asbestos at work, because there really can be significant financial compensation for these types of individuals. For more information diagnosed victims of mesothelioma, victims of lung cancer, or their family members are encouraged to contact the Lu...

Mesothelioma Victims Center Urges A Diagnosed Victim Of Mesothelioma Or Their Family Members To Call Them For Instant Access To The Nation's Best Settlement Attorneys

The Mesothelioma Victims Center says, "If you are a diagnosed victim of mesothelioma, or their family members we cannot emphasize enough how important it is to have the absolute best mesothelioma attorneys in the nation in your corner, fighting for your mesothelioma claim, and settlement compensation, because these extremely skilled specialists really do produce much better compensation resul...

Dr Zizmor and Other Dermatologists Urge Skin Cancer Prevention and Detection

During Men's Health Month, Dr. Zizmor and other top dermatologists are urging patients to take the proper precautions to prevent and detect skin cancer. New York, NY (PRWEB) June 20, 2013 During Men's Health Month, Dr. Zizmor and other top dermatologists are urging patients to take the proper precautions to prevent and detect skin cancer by encouraging frequent examinations of suspicious...

Midwest Reproductive Symposium Showcases Latest Medical Advancements in Reproductive Endocrinology

Fertility Centers of Illinois hosts Chicago meeting June 20-22, 2013. Chicago, IL (PRWEB) June 20, 2013 The Midwest Reproductive Symposium, held June 20-22, 2013 in Chicago, IL. will draw top national and international leaders in the field of reproductive endocrinology. The symposium, hosted by Fertility Centers of Illinois, will discuss advancements, techniques, and treatment modalities relevant...

Sirtex To Distribute Surefire Medical's Innovative Infusion System in Australia and Asia Pacific Markets

SYDNEY and WESTMINSTER, Colo., June 20, 2013 /PRNewswire/ -- Sirtex Medical Limited (ASX: SRX) and US-based Surefire Medical today announced a sales and marketing partnership to distribute Surefire's range of innovative infusion systems and specialty catheters for the interventional radiology and oncology markets. The agreement will see Sirtex exclusively distribute the Surefire Medical range of...

Ambrx, Zhejiang collaborate on breast cancer antibody drug conjugate development

US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer.

Medical Conferences International Inc. (MCII) to Hold Skin Cancer Certification Workshop at Intercontinental Chicago O’Hare Hotel June 28-29, 2013

Boca Raton, FL, June 20, 2013 --(PR.com)-- The US Primary Care Skin Cancer Medicine Certification is a two-day CME accredited course hosted by Medical Conferences International Inc. (MCII) and HealthCert. The course is designed to provide an introductory training in the diagnosis and management of skin cancer medicine in the primary care setting. This certificate course will provide the clinician...

Epitope Diagnostics Launches the First Commercially Available Immunoassay Kits Exclusively for the Quantitative Measurement of Antibody Drug Conjugate Level (ADC)

San Diego, CA, June 20, 2013 --(PR.com)-- Antibody-drug conjugates (ADCs) are a new type of targeted therapy which are very promising in cancer treatment, with the FDA approval of ADCETRIS® (brentuximab vedotin). ADCs are cancer cell specific monoclonal antibodies that are conjugated with highly potent cyotoxics via a specific linker, which delivers and releases the drug inside the tumor cel...

Cancer-Proof "Goo" From Naked Mole Rats May Lead To New Treatments

Despite its long lifespan, the naked mole rat has never been known to get cancer. Now scientists in the US have discovered this is thanks to a simple chemical in the "goo" of the rodent's skin, which they suggest could lead to new anti-cancer tre...

High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat

The naked mole rat (Heterocephalus glaber) displays exceptional longevity, with a maximum lifespan exceeding 30 years. This is the longest reported lifespan for a rodent species and is especially striking considering the small body mass of the nake...

Ibrutinib shows remarkable promise for treatment of mantle cell lymphoma

In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).

Researchers develop method to identify aggressive prostate cancers

Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nu...

Advanced Breast Cancer Campaign, Here & Now, Launches In The UK As It's Revealed Nearly 8 In 10 Do Not Know That The Disease Is Incurable

New research shows significant disparities in UK public's awareness of advanced breast cancer (ABC)versus early breast cancer New findings from a public survey commissioned by Novartis Oncology have revealed that although 81%1 of UK respondents are a...

Purdue Researchers Seek Treatment For New MERS Coronavirus

A pair of Purdue University researchers who in the past created compounds to block the SARS virus are now tackling the new Middle East respiratory syndrome coronavirus, or MERS-CoV. The team's successful work on SARS paved the way for them to swiftly...

Japan MHLW To Carry Out Survey After Cases Of Pain Following Cervical Cancer Vaccination

Japan’s MHLW has decided to investigate the relationship between cervical cancer vaccines and the frequency of pain following inoculation after several reported cases.

Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)

DUBLIN, Calif., June 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that updated clinical data from the dose escalation part of a randomized phase 1/2 clinical trial of subcutaneous SGI-110, a novel hypomethylating agent, in patients with relapsed/refr...

New Resistance Mechanism To Chemotherapy Identified In Breast And Ovarian Cancer

It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumours are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2. In patients with these mutation...

Missing Link In Connection Between Social Stress And Triple-Negative Breast Cancer May Be Fat Cells In Breast

Local chemical signals released by fat cells in the mammary gland appear to provide a crucial link between exposure to unrelenting social stressors early in life, and the subsequent development of breast cancer, researchers from the University of Chi...

Atossa Genetics Signs Distribution Agreement With Fisher HealthCare

SEATTLE, WA -- (Marketwired) -- 06/20/13 -- Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has signed an agreement with Fisher HealthCare Inc., part of Thermo Fisher Scientific, for distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Atossa's MASCT system is used by physicians and nurses to co...